2024-2029 Canada Anemia Diagnostic Testing Market Assessment--2024 Supplier Shares and 2024-2029 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities

October 2024 | | ID: 2F23ACD21F24EN
Venture Planning Group

Abstracts

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source, including:

• Supplier Sales and Shares by Segment and Test
• Volume and Sales Segment Forecasts by Test
• Supplier Strategies and SWOT Analysis
• Instrumentation Pipeline
• Emerging Technologies
• Opportunities for New Analyzers and Consumables
• Market Challenges and Risks

The report provides test volume and sales forecasts by market segment for the following assays:
CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D
The report is available by section, and can be customized to specific information needs and budget.
Rationale
During the next decade, the anemia diagnostics market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

Contents

Introduction
Worldwide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
The report provides segment test volume and sales forecasts for the following tests:
Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran,
Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium,
Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban,
Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin
and Warfarin.
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alfa
Wassermann, AMS, Awareness Technologies, Beckman
Coulter, Binding Site, bioMerieux, Carolina Chemistries,
DiaSorin, Grifols, Horiba, Medica, Nova Biomedical,
Ortho-Clinical Diagnostics, Polymedco, Randox, Roche,
Siemens Healthineers, Tosoh, Vital Diagnostics and
other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential
Applications

1. MONOCLONAL AND POLYCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays
-Overview
-ELISA
-EMIT
-Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

3. TANDEM MASS SPEC

4. IT AND AUTOMATION

5. DRY CHEMISTRY

6. BIOSENSORS

Table of Contents (Continued)
France: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Japan: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Table of Contents (Continued)
Spain: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
USA: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS

5. EMERGING SUPPLIERS

6. MAJOR TYPES OF DISTRIBUTORS

7. MARKET SEGMENTATION

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Table of Contents (Continued)
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
IL/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
List of Tables
France, Hospital Laboratories, TDM
Diagnostics Market Forecast by Assay
France, Commercial/Private Laboratories,
TDM Diagnostics Market Forecast by Assay
France, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
Germany, Laboratories Performing TDM
Tests By Market Segment
Germany, Hospital Laboratories Performing
TDM Tests By Bed Size
Germany, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume
Germany, TDM Test Volume Forecast By Market
Segment
Germany, Hospital Laboratories, TDM
Test Volume Forecast by Assay
Germany, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
Germany, Physician Offices/Group
Practices, TDM Test Volume Forecast by Assay
Germany, TDM Reagent Market Forecast
By Market Segment
Germany, Hospital Laboratories, TDM
Reagent Market Forecast by Assay
Germany, Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
Germany, Physician Offices/Group
Practices, TDM Reagent Market Forecast by Assay